Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 3,039 3,329 7,145 6,535
General and administrative 2,434 1,653 4,373 3,463
Depreciation and amortization 44 52 88 98
Total operating expenses 5,517 5,034 11,606 10,096
Loss from operations (5,517) (5,034) (11,606) (10,096)
Other income (loss):        
Gain (loss) from change in fair value of warrant liability 1,173 (5,099) 2,750 (1,254)
Other income, net 8 17 18 22
Interest income, net 92 4 149 7
Net loss $ (4,244) $ (10,112) $ (8,689) $ (11,321)
Net loss per common share - basic and diluted (in dollars per share) $ (0.15) $ (1.02) $ (0.35) $ (1.24)
Weighted average common shares outstanding, basic and diluted (in shares) 28,451,532 9,913,878 25,148,399 9,117,856
Net loss $ (4,244) $ (10,112) $ (8,689) $ (11,321)
Other comprehensive income (loss):        
Foreign currency translation (6) 25 (10) (8)
Comprehensive loss $ (4,250) $ (10,087) $ (8,699) $ (11,329)